Amgen Inc. (FRA:AMG)
250.30
+0.55 (0.22%)
Last updated: Aug 15, 2025
Amgen Revenue
Amgen had revenue of $9.18B USD in the quarter ending June 30, 2025, with 9.43% growth. This brings the company's revenue in the last twelve months to $34.92B, up 12.88% year-over-year. In the year 2024, Amgen had annual revenue of $33.42B with 18.57% growth.
Revenue (ttm)
$34.92B
Revenue Growth
+12.88%
P/S Ratio
4.51
Revenue / Employee
$1.25M
Employees
28,000
Market Cap
134.14B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 33.42B | 5.23B | 18.57% |
Dec 31, 2023 | 28.19B | 1.87B | 7.09% |
Dec 31, 2022 | 26.32B | 344.00M | 1.32% |
Dec 31, 2021 | 25.98B | 555.00M | 2.18% |
Dec 31, 2020 | 25.42B | 2.06B | 8.83% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.89B |
Siemens Aktiengesellschaft | 78.30B |
Deutsche Telekom AG | 120.55B |
Allianz SE | 109.02B |
Siemens Energy AG | 38.39B |
Rheinmetall AG | 10.67B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.33B |
Deutsche Bank Aktiengesellschaft | 30.07B |
Amgen News
- 8 days ago - August Dogs Of The Dow Unleashed 19 'Safer' Dividend Buys - Seeking Alpha
- 9 days ago - Amgen Stock Sinks As Market Eyes MariTide's Next Move - Benzinga
- 9 days ago - Amgen Stock Sinks As Market Eyes MariTide's Next Move - Benzinga
- 9 days ago - Planet Fitness Pumps Up FY25 Sales Guide To $1.43 Billion After Smashing Q2 Results - Benzinga
- 9 days ago - RFK Jr. Sued By Eli Lilly, Amgen Over Drug Discount Program - Benzinga
- 9 days ago - Why I Still Don't Think Amgen Is A Buy - Seeking Alpha
- 9 days ago - Amgen Delivers Beat And Raise Quarter; Has Strong Late-Stage Pipeline - Benzinga
- 10 days ago - Amgen in charts: Key drug sales drop in Q2, but Otezla sees continued growth - Seeking Alpha